| Literature DB >> 35840810 |
Nathalia Santos Carvalho1, Julia Borges Paes Lemes1,2, Marco Pagliusi1,3, Ana Carolina Dos Santos Machado1, Kauê Franco Malange1,2, Laís Passariello Pral4, José Luís Fachi4, Catarine Massucato Nishijima1, Gilson Gonçalves Dos Santos2, Claudia Herrera Tambeli1, Cesar Renato Sartori1, Marco Aurélio Ramirez Vinolo4, Carlos Amilcar Parada5.
Abstract
Inflammation is a vital process for the injured tissue restoration and one of its hallmarks is inflammatory hyperalgesia. The cyclooxygenase (COX) pathway is strongly related to the inflammatory and painful process. Usually, the COX-1 isoform is described as homeostatic, while COX-2 is characterized as inducible in inflammatory conditions. Although it is well known that neutrophil cells are the first to arrive at the inflamed site and the major source of COX-2 is still unknown, the specific role of neutrophil-derived COX-2 in the pain process is. Thus, in the present study, we demonstrate for the first time that neutrophil-derived COX-2 plays a key role in peripheral inflammatory hyperalgesia. Conditional knockout mice for COX-2 in neutrophils (COX-2 fl/fl: Mrp8cre±) exhibited higher pain sensitivity after carrageenan (CG) injection and long-lasting IL-1β-induced hyperalgesia compared with the control group (COX-2 fl/fl). Also, CG-induced inflammation in COX-2 fl/fl: Mrp8cre± mice showed COX-1 overexpression, and increased neutrophil migration and pro-inflammatory cytokines (e.g., IL-1β and CXCL1). These findings revealed that neutrophil COX-2 has an important role in the regulation of inflammatory hyperalgesia.Entities:
Keywords: Cytokines; Eicosanoids; Inflammation; Leukocyte; Pain
Year: 2022 PMID: 35840810 DOI: 10.1007/s10753-022-01690-5
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.657